How Contactless Screening Supports Universal Health Coverage Goals

Universal health coverage remains one of those goals that everyone agrees on and almost nobody is on track to meet. The WHO and World Bank's 2025 Global Monitoring Report put the number at 4.6 billion people worldwide who still lack access to a basic package of health services. Another 2.1 billion face financial hardship when they try to get care. We are past the halfway point on the Sustainable Development Goals timeline, and the gap between ambition and reality is not shrinking fast enough.

The reasons are familiar. There are not enough health workers. Clinics are too far away. Equipment is too expensive. Lab-based screening requires infrastructure that does not exist in many rural areas. What has changed in the past few years is the emergence of contactless screening technology that runs on the smartphones community health workers already carry. This is not a theoretical capability anymore. Programs in East Africa and South Asia are using camera-based vital signs measurement to screen patients in places where no clinical equipment exists.

"Digital health will not achieve universal health coverage on its own, but universal health coverage will not be achieved without digital health." — Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, 2024 UHC Day remarks

What contactless screening actually does for coverage gaps

The core problem with reaching universal health coverage in low-income countries is not a lack of will. It is logistics. You cannot screen a population for hypertension, cardiovascular risk, or respiratory conditions if every screening event requires a blood pressure cuff, a pulse oximeter, trained clinical staff, and a clinic with electricity. That model does not scale to the last mile.

Contactless screening using remote photoplethysmography (rPPG) changes the equipment equation. A smartphone camera captures subtle changes in facial skin color caused by blood flow. From a 30-second video, algorithms extract heart rate, respiratory rate, blood oxygen estimates, and stress indicators. The technology is not perfect and is still being validated across diverse populations, but the practical implications for population-level screening are real.

A 2025 review in Frontiers in Digital Health examined 96 rPPG studies, finding that 54 directly tested the technology in applied settings. Heart rate and respiratory rate measurements had the strongest evidence base. Blood pressure estimation and SpO2 remained areas of active research with more variable results, but the trajectory is toward broader clinical applicability.

Screening approach	Equipment required	Staff training needed	Cost per screening	Scalability in rural areas
Traditional clinical screening	BP cuff, pulse oximeter, stethoscope, thermometer	Certified nurse or clinical officer	$15–40 USD	Low — requires clinic infrastructure
Mobile clinic outreach	Portable equipment, generator, vehicle	Clinical team of 3–5	$8–20 USD per patient	Medium — limited by vehicle access and schedule
CHW with basic tools	BP cuff, thermometer	2–4 weeks CHW training	$3–8 USD	Medium — limited by equipment supply chain
Contactless smartphone screening	Smartphone with camera	Basic app training (hours)	Under $1 USD	High — works anywhere with a phone

The cost difference matters enormously when you are trying to screen millions of people across geographies where per-capita health spending is under $50 per year. The UN reported in December 2024 that underinvestment in health systems threatens UHC goals globally, with the poorest populations bearing the greatest burden. Reducing the cost per screening event is one of the few levers that can move population coverage numbers at scale.

How community health workers use contactless screening in practice

Community health workers are the backbone of primary care delivery in most of Sub-Saharan Africa. Africa CDC estimated in 2024 that the continent has a $4.4 billion annual funding gap for CHW programs. These workers are often volunteers or receive minimal stipends. They operate in areas where the nearest clinic may be hours away by foot.

Adding contactless screening to a CHW's workflow does not require new infrastructure. The CHW already has a phone. The screening app runs locally, which matters in areas with intermittent connectivity. A household visit that previously consisted of a questionnaire and visual assessment can now include actual physiological measurements.

Programs deployed in Uganda and Rwanda have demonstrated this model. CHWs conducting door-to-door maternal health visits use smartphone-based screening to capture vitals from pregnant women who would otherwise have no monitoring between infrequent antenatal clinic visits. The data feeds into the national health information system — typically DHIS2, which is used in over 80 countries — so district health officers can identify high-risk cases and allocate resources accordingly.

Maternal and neonatal health screening

Maternal mortality in Sub-Saharan Africa remains the highest globally, with the WHO reporting approximately 545 maternal deaths per 100,000 live births in the region. Many of these deaths involve conditions — pre-eclampsia, postpartum hemorrhage risk factors, cardiovascular complications — that show early warning signs in vital signs data. The problem is that women in rural areas often see a health provider only once or twice during pregnancy.

Contactless screening lets CHWs monitor vital signs trends over time without expensive equipment. Monthly or even weekly check-ins become feasible when each screening takes 30 seconds and requires no consumables.

Chronic disease screening at population scale

Hypertension affects an estimated 1.3 billion people globally, according to the WHO's 2023 global report on the condition. In Africa, detection rates are particularly low — many people with hypertension have never been diagnosed because they have never had their blood pressure measured. Traditional screening requires equipment. Contactless approaches can turn any community gathering — a market, a church, a school — into a screening opportunity.

A 2025 study published in JMIR by Salifu et al. reviewed 25 years of digital health implementations in low- and middle-income countries and found that programs integrated into existing national health information infrastructure were significantly more likely to survive beyond their initial funding period. This is where contactless screening has an advantage: it generates structured data that flows into systems governments already maintain, rather than creating parallel data silos that disappear when a project ends.

What the evidence says about digital health and UHC

The link between digital health tools and UHC progress is supported by a growing body of evidence, though the field is still young enough that most studies are observational rather than randomized.

A 2025 systematic review published in Frontiers in Digital Health examined how digital health technologies improve health financing and service delivery in Africa. The authors found that mobile health interventions consistently improved service utilization in areas including antenatal care attendance, vaccination coverage, and chronic disease follow-up. The effect was strongest when digital tools were integrated into existing health system workflows rather than deployed as standalone programs.

The WHO's Global Strategy on Digital Health (2020–2025) explicitly tied digital health adoption to UHC progress, identifying four priority areas: governance, financing, technology, and workforce capacity. The updated strategy recognizes that digital tools can reduce costs, improve data quality, and extend the reach of limited health workforces. But it also warned against fragmentation — the proliferation of disconnected digital health projects that don't talk to each other and collapse when donor funding ends.

Omorou et al., writing in the Journal of Medical Internet Research in 2024, assessed an mHealth screening application used by community health workers in Rwanda. They found high feasibility and acceptability scores from both CHWs and patients, with the main barriers being phone battery life and network connectivity in remote areas. The clinical barriers were minimal — the technology worked. The logistical barriers were real but solvable.

The economics of contactless screening for UHC

The arithmetic is straightforward. To achieve UHC, countries need to screen and treat vastly more people than they currently reach. Traditional clinical infrastructure cannot scale fast enough. Building clinics costs millions. Training clinical staff takes years. Equipment has ongoing maintenance and supply chain costs.

Contactless screening does not replace clinics or doctors. What it does is move the initial screening step — the point at which someone is identified as needing further care — out of the clinic and into the community. This is the concept of task-shifting, and it has been a cornerstone of global health strategy for decades. Digital tools make task-shifting more effective by giving community-level workers capabilities that previously required clinical equipment.

UHC building block	Traditional approach	Contactless screening contribution
Service coverage	Limited by clinic density and staffing	Extends screening to any location with a CHW and a phone
Financial protection	Lab tests and clinical visits impose costs on patients	Near-zero marginal cost per screening reduces financial barriers
Health workforce capacity	Requires years of clinical training per worker	CHWs trained in hours can conduct physiological screening
Health information systems	Paper-based or fragmented digital records	Structured data feeds directly into DHIS2 or equivalent
Essential medicines access	Screening bottleneck delays treatment initiation	Earlier detection means earlier referral and treatment

The World Bank's April 2024 analysis noted that half the world cannot access healthcare, and that innovative approaches to extending coverage — particularly through digital tools — are necessary to close the gap. The 2025 Global Monitoring Report reinforced this, finding that while most countries are making some progress toward UHC, the rate of improvement is insufficient to meet the 2030 SDG target.

Current research and evidence

Research on contactless vital signs screening continues to accelerate. A 2025 review published in PMC covering remote photoplethysmography for health assessment catalogued the technology's current capabilities and limitations. Heart rate measurement is well-established, with multiple studies showing agreement with clinical-grade devices within acceptable error margins. Respiratory rate estimation is maturing. Blood pressure and SpO2 estimation remain active research areas where accuracy varies by population, lighting conditions, and skin tone.

The reliability question is important and should not be glossed over. A separate 2025 study in PMC specifically investigated rPPG reliability under low-light conditions — the exact scenario a CHW in a rural home would face. The researchers found degraded performance in very low light but acceptable results in moderate indoor lighting, which describes most real-world screening environments.

For UHC purposes, the relevant question is not whether contactless screening matches the precision of hospital-grade equipment. It is whether it can reliably identify people who need further clinical assessment. As a triage and screening tool rather than a diagnostic instrument, the evidence increasingly supports its utility.

A 2026 study published in Nature Digital Medicine by researchers working on adaptive physiology-informed correction for rPPG signals showed improved accuracy across diverse skin tones and lighting conditions. This matters for global health deployment, where the population being screened is diverse by definition.

Frequently asked questions

Can contactless screening replace clinical health assessments?

No. Contactless screening is a triage and monitoring tool, not a diagnostic replacement. It identifies people who may need clinical follow-up and tracks vital signs trends over time. The value is in reaching people who currently get no screening at all.

How accurate is smartphone-based vital signs screening?

Heart rate measurement via rPPG has the strongest evidence base, with multiple studies showing it performs within clinically acceptable error ranges compared to contact-based pulse oximeters. Respiratory rate estimation is also well-supported. Blood pressure and blood oxygen estimation are improving but still being validated across diverse populations and conditions.

Does contactless screening work without internet access?

Yes. Most contactless screening applications are designed to process vital signs data on the device itself. Results can be stored locally and synced to health information systems when connectivity becomes available. This offline-first design is specifically intended for low-resource settings.

What does contactless screening cost per patient?

The marginal cost per screening is under $1 USD, and in many deployment models it approaches zero since the smartphone is an existing asset. This compares to $15–40 for traditional clinical screening, making it viable for population-scale deployment in countries with per-capita health budgets under $50 per year.

---

Organizations like Circadify are working to bring contactless vital signs screening to the field, particularly in East African deployments where the gap between health infrastructure and population need is widest. For more on how smartphone-based screening is being deployed in global health contexts, visit circadify.com/blog.

If you are interested in how these programs are structured on the ground, see our post on building sustainable health tech programs in low-income countries and how community health workers use contactless screening in the field.